Mgr. Petra Vychytilová, Ph.D.
Junior researcher, Ondřej Slabý Research Group
Office: bldg. C03/116
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 3559 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 93
2017
-
MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9
Oncogenesis, year: 2017, volume: 6, edition: 11, DOI
2016
-
Decreased expression levels of PIWIL1, PIWIL2, and PIWIL4 are associated with worse survival in renal cell carcinoma patients
ONCOTARGETS AND THERAPY, year: 2016, volume: 9, edition: January, DOI
-
DETECTION OF ALTERED MIRNA AND PIRNA EXPRESSION LEVELS IN RENAL CELL CARCINOMA BY NGS
Year: 2016, type: Conference abstract
-
Efficacy and Toxicity of Panitumumab After Progression on Cetuximab and Predictive Value of MiR-31-5p in Metastatic Wild-type KRAS Colorectal Cancer Patients
Anticancer Research, year: 2016, volume: 36, edition: 9, DOI
-
Genome-wide microRNA Expression Profiling in Primary Tumors and Matched Liver Metastasis of Patients with Colorectal Cancer
Cancer Genomics & Proteomics, year: 2016, volume: 13, edition: 4
-
IDENTIFIKACE CIRKULUJÍCÍCH MIKRORNA S DIAGNOSTICKÝM A PROGNOSTICKÝM POTENCIÁLEM U PACIENTŮ S KOLOREKTÁLNÍM KARCINOMEM S VYUŽITÍM SEKVENOVÁNÍ NOVÉ GENERACE
Year: 2016, type: Conference abstract
-
Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer
Oncotarget, year: 2016, volume: 7, edition: 1, DOI
-
MikroRNA-215 jako potenciální terapeutický cíl u kolorektálního karcinomu
Year: 2016, type: Conference abstract
-
MiR-215 jako potenciální terapeutický cíl: pilotní studie systémového podání miRNA-mimics v animálním modelu kolorektálního karcinomu
Year: 2016, type: Conference abstract
-
Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapy
ONCOTARGETS AND THERAPY, year: 2016, volume: 9, edition: July, DOI